Ivan I. Maximov1, Aram Tonoyan2, Daniel Edelhoff1, Igor Pronin2, and Dieter Suter1
1TU Dortmund University, Dortmund, Germany, 2Burdenko Neurosurgery Institute, Moscow, Russian Federation
Synopsis
Diffusion weighted imaging is very powerful technique allows one to diagnose and differentiate glioma malignancy in vivo. Recently, the non-Gaussian diffusion models exhibited their efficacy in a detection of microsctructure changes for low and high grade gliomas. In this study we perform a comparative analysis of four diffusion models (DTI, DKI, two- and three-compartment models) in ability to provide a quantitative measure of the gliomas malignancy in vivo.Purpose
We
provide a quantitative comparison of characteristic diffusion metrics
obtained by four diffusion models (DTI, DKI, two- and
three-compartment models of diffusion) in ability
to distinguish the glioma malignancy grades II, III, and IV from in vivo
datasets.
Methods
A
group of 15 patients with different supratentorial gliomas: 5
subjects with grade II, 5 subjects with grade III, and 5 subjects
with grade IV, underwent the diffusion weighted measurements (
b
= 1000, 2500 s/mm
2, 60 diffusion directions, 3 mm
3
isotropic resolution). The used workflow is represented in Fig.1.
Initially, all datasets were corrected for subject motion and eddy
current distortions using FSL. Appropriate
b-matrix rotations
were performed. The noise was corrected using a χ
2
distribution function
1. All raw datasets were interpolated
using the cubic spline method and anisotropic diffusion filtering up
to 1.5 mm
3 isotropic resolution
2. The DTI, DKI,
and two-compartment model metrics such as fractional anisotropy (FA),
kurtosis anisotropy
3 (KA), apparent water fraction
4
(AWF), and tortuosity
4 (TORT) were evaluated using
ExploreDTI
5 and the linear weighted estimator. Neurite
orientation dispersion and density imaging (NODDI) metrics such as
orientation dispersion index (ODI) and intra-axonal volume fraction
(TD) were estimated in two stage: at the beginning the whole brain
maps were evaluated
6. Next the new masks (see Fig.1) were
created in regions with the suspicious results of an optimisation
(the values equal to 0.704833 in ODI maps), and a two-step
optimisation was rerun for these regions. This improvement allows us
to obtain corrected values of ODI/TD in the area of tumour and edema.
For the statistical analysis we used only highest glioma grade
regions in each subject chosen by hand by a trained radiologist.
Results
In
Figure 2 we present an example of three patients with different
gliomas and corresponding masks.
One
can see histograms of estimated metrics (normalised and averaged over
the groups) FA, KA, AWF, TORT, TD, and ODI. In Figure 3 we presented
the scatter plots of different diffusion metrics.
Discussion
Diffusion-weighted
imaging provides useful
information about microstructure difference between healthy and
diseased brain tissue. At the moment, a clinical “gold standard”
such as DTI and the recently popular, DKI metrics are used as the
biomarkers in a differentiation of glioma grades
7. However, as we have
shown (see Figs. 2,3) the diffusion models based on two- and
three-compartment models allow one to get better contrast and richer information about
the structure changes in tumour tissue depending on the glioma grade.
In particular, the NODDI metrics which originally were developed for a healthy
tissue exhibit a growing contribution of extra compartment
based on cancer cells to the diffusion signal. It can be treated as a very sensitive
biomarker of glioma malignancy and provides a good signaling metrics in
glioma grade analysis.
Conclusion
In
conclusion we demonstrated the feasibility of using diffusion models
based on compartmentalization of brain tissue
7.8. We have
shown that ODI, TD, and AWF maps provided unique contrasts within
regions with highest glioma malignancy and allow one to make a
separation
within low- and high glioma grades, including splitting inside of
high-grade gliomas.
Acknowledgements
IIM and DS thank DFG (SU 192/32-1) for a partial support.References
1.
Aja-Fernandez et al., Magn. Reson. Med. 65 (2011) 1195.
2.
Yushkevich et al., NeuroImage 31 (2006) 1116.
3.
Poot et al., IEEE Trans. MI 29 (2010) 819.
4.
Fieremans et al., NeuroImage 58 (2011) 177.
5.
Leemans et al., Proc ISMRM 17 (2009) 3537.
6.
Zhang et al., NeuroImage 61 (2012) 1000.
7.
Van Cauter et al., Radiology 263 (2012) 492.
8.
Wen et al., NeuroImage: Clinical 9 (2015) 291.